Skip to main content
. 2022 Feb 11;30(6):4813–4821. doi: 10.1007/s00520-022-06833-w

Table 1.

Patient characteristics at baseline

Characteristics Study population (n = 50)
Sex Female 42 84.0%
Male 8 16.0%
Age Mean (SD) 54.3 (13.7)
 ≤ 45 years 14 28.0%
 ≤ 55 years 17 34.0%
 ≤ 65 years 7 14.0%
 ≤ 75 years 8 16.0%
 > 75 years 4 8.0%
Body mass index  < 25 21 42.0%
25– < 30 19 38.0%
 ≥ 30 10 20.0%
School degree University-entrance diplomaa 22 44.0%
High school degreeb 12 24.0%
Secondary school degreec 14 28.0%
Missing 2 4.0%
Cancer type Breast cancer 33 66.0%
Skin cancer 9 18.0%
Uveal cancer 2 4.0%
Otherd 6 12.0%
Treatment Chemotherapy 31 62.0%
Radiotherapy 18 36.0%
Endocrine therapy 8 16.0%
Immune therapy 15 30.0%
Ongoing 46 92.0%
Completed 4 8.0%
Metastases No 30 60.0%
Yes 20 40.0%
Time since diagnosis 12 + months 18 36.0%
 < 12 months 13 26.0%
 < 6 months 14 28.0%
Missing 5 10.0%
Physical fatiguee Median (Q1, Q3) 53 (27, 80)
Emotional fatiguee Median (Q1, Q3) 33 (11, 44)
Cognitive fatiguee Median (Q1, Q3) 17 (0, 33)

aGerman “(Fach-)Abitur”

bGerman “Mittlere Reife”

cGerman “Hauptschulabschluss”

dOther: each n = 1 of lymphoma, gastric, pancreatic, lung, neuroendocrine, and endometrial cancer

eAssessed with the multidimensional EORTC QLQ-FA12 questionnaires; 0–100 scale